Literature DB >> 22298064

The prevalence of defensive orthopaedic imaging: a prospective practice audit in Pennsylvania.

Robert A Miller1, Norma Rendon Sampson, John M Flynn.   

Abstract

BACKGROUND: Defensive medicine has been identified as an area of wasteful health-care spending. Estimates of its prevalence and its contribution to the cost of defensive practices have varied widely. To date, there has been no prospective evaluation of the use of defensive medicine for musculoskeletal conditions.
METHODS: Members of the Pennsylvania Orthopaedic Society were queried by means of an anonymous, prospective audit of consecutive imaging decisions in their clinical practice. For each image order, respondents recorded the modality, the body region imaged, and whether the imaging was "required for clinical care" or "ordered for defensive reasons." We evaluated the proportion of images that were ordered defensively, identified demographic differences with use of the chi-square test of independence, and calculated the contribution of defensive imaging to the total cost with use of 2009 Medicare reimbursement rates.
RESULTS: Seventy-two orthopaedists recorded 2068 imaging decisions made during the day that their practice was audited. Defensive imaging represented 19.1% (396) of the orders and 34.7% ($113,675) of the total cost ($327,414). Magnetic resonance imaging (MRI) represented 48.7% of the defensive orders, and 38.5% (193) of the 501 MRIs were ordered for defensive reasons. The proportion of defensive imaging ordered by orthopaedists who had been sued for medical malpractice within the previous five years was significantly greater than the proportion ordered by those who had not been sued during the same time frame (24.6% compared with 15.1%, p < 0.001). The proportion of defensive imaging ordered by orthopaedists who had been in practice for more than fifteen years was significantly greater than the proportion ordered by those who had less experience (20.8% compared with 17.1%, p = 0.03).
CONCLUSIONS: In a prospective practice audit of orthopaedists, defensive imaging was found to be both common and costly. Recent litigation experiences and longer duration of orthopaedic practice were independent predictors of an increased use of defensive practices in ordering imaging studies. This real-time audit showed that a large proportion of MRI studies were ordered for primarily defensive medicine reasons.

Entities:  

Mesh:

Year:  2012        PMID: 22298064     DOI: 10.2106/JBJS.K.00646

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  7 in total

1.  A perspective on the health care expenditures for defensive medicine.

Authors:  Michael Osti; Johannes Steyrer
Journal:  Eur J Health Econ       Date:  2017-05

2.  Radiographic Enchondroma Surveillance: Assessing Clinical Outcomes and Costs Effectiveness.

Authors:  Craig C Akoh; Ethan Craig; Alexander M Troester; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2019

Review 3.  Current evidence for spinal X-ray use in the chiropractic profession: a narrative review.

Authors:  Hazel J Jenkins; Aron S Downie; Craig S Moore; Simon D French
Journal:  Chiropr Man Therap       Date:  2018-11-21

4.  2005 to 2014 CT and MRI Utilization Trends in the Context of a Nondenial Prior Authorization Program.

Authors:  Adam C Powell; David C Levin; Erin M Kren; Roy A Beveridge; James W Long; Amit K Gupta
Journal:  Health Serv Res Manag Epidemiol       Date:  2017-11-02

5.  The practice of defensive medicine among hospital doctors in the United Kingdom.

Authors:  Osman Ortashi; Jaspal Virdee; Rudaina Hassan; Tomasz Mutrynowski; Fikri Abu-Zidan
Journal:  BMC Med Ethics       Date:  2013-10-29       Impact factor: 2.652

Review 6.  Clinical errors and medical negligence.

Authors:  Femi Oyebode
Journal:  Med Princ Pract       Date:  2013-01-18       Impact factor: 1.927

7.  How defensive medicine is defined in European medical literature: a systematic review.

Authors:  Nathalie Baungaard; Pia Ladeby Skovvang; Elisabeth Assing Hvidt; Helle Gerbild; Merethe Kirstine Andersen; Jesper Lykkegaard
Journal:  BMJ Open       Date:  2022-01-20       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.